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Abstract
Background: Telomere length is a putative biomarker of ageing, morbidity and mortality.
Its application is hampered by lack of widely applicable reference ranges and uncertainty
regarding the present limits of measurement reproducibility within and between
laboratories.
Methods: We instigated an international collaborative study of telomere length assess-
ment: 10 different laboratories, employing 3 different techniques [Southern blotting, sin-
gle telomere length analysis (STELA) and real-time quantitative PCR (qPCR)] performed
two rounds of fully blinded measurements on 10 human DNA samples per round to
enable unbiased assessment of intra- and inter-batch variation between laboratories and
techniques.
Results: Absolute results from different laboratories differed widely and could thus not
be compared directly, but rankings of relative telomere lengths were highly correlated
(correlation coefficients of 0.63–0.99). Intra-technique correlations were similar for
Southern blotting and qPCR and were stronger than inter-technique ones. However,
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inter-laboratory coefficients of variation (CVs) averaged about 10% for Southern blotting
and STELA and more than 20% for qPCR. This difference was compensated for by a
higher dynamic range for the qPCR method as shown by equal variance after z-scoring.
Technical variation per laboratory, measured as median of intra- and inter-batch CVs,
ranged from 1.4% to 9.5%, with differences between laboratories only marginally signifi-
cant (P¼ 0.06). Gel-based and PCR-based techniques were not different in accuracy.
Conclusions: Intra- and inter-laboratory technical variation severely limits the usefulness
of data pooling and excludes sharing of reference ranges between laboratories. We
propose to establish a common set of physical telomere length standards to improve
comparability of telomere length estimates between laboratories.
Key words: : Ageing, telomeres, variation, biomarker, human
Introduction
Telomere length (TL) in peripheral blood has been associ-
ated in multiple studies with progression of human ageing,
mortality and risk of age-related diseases.1–10 However,
whether telomere length is a ‘good’ biomarker of ageing, i.e.
whether it has relevant diagnostic potential in the context of
ageing and age-related disease, is far from evident.11–13 This
is at least partially due to methodological issues, specifically
the absence of any widely accepted reference standards and
uncertainty about the reproducibility of results both within
and between laboratories and techniques.14,15
A wide range of methods have been developed to meas-
ure TL such as: (i) Terminal Restriction Fragment (TRF)
analysis by hybridization of digested and electrophoresed
DNA with telomere sequence probes (Southern blot-
ting);1,16,17 (ii) single telomere amplification and blotting
(STELA)18 in which telomeres on individual chromosomes
are first PCR-amplified and their length then measured by
gel electrophoresis; (iii) flow cytometry of cells following
hybridization with fluorescent peptide nucleic acid (PNA)
probes (Flow-FISH);19,20 (iv) quantitative fluorescence in
situ hybridization with fluorescent telomere PNA probes
(qFISH);21 and (v) qPCR assay of telomere repeats using
mismatched primers22,23 where telomere length is ex-
pressed as the template amount ratio between telomeres
and a single copy gene. Given that human telomere length
is increasingly regarded as a possible biomarker of ageing
with budding commercial potential, there is a growing
need to provide evidence that different laboratories can
provide reliable and consistent assessment of telomere
length. Moreover, telomere data are increasingly included
in large-scale genetic (GWS) and phenotypic trait analyses,
and for these the combination of data from different labo-
ratories becomes necessary, requiring information about
inter-laboratory reproducibility. Self-reported indicators
of reproducibility, measured as inter-batch coefficients
of variation (CV), differ widely between laboratories and
studies, covering a range from about 2 to almost
30%.8,12,14 Independent assessments of measurement
accuracy have not been performed so far, with the single
exception of only one single fully blinded study, which
included just two laboratories.14 However, there is likely
significant methodological variation between laboratories
for every technique, such that larger comparative studies
are needed to enable an unbiased assessment of the state of
the art as well as a meaningful comparison between the
capabilities of different techniques to measure telomere
length accurately and reproducibly.
To comprehensively and independently assess the
reproducibility of the method and the degree of consistency
between different laboratories and techniques, an interna-
tional collaborative study was conducted in which a num-
ber of coded samples of DNA were shipped to 10 expert
laboratories around the world, that performed two rounds
Key Messages
• Rankings are very similar if different laboratories measure telomere lengths in the same samples.
• However, quantitative results from different laboratories are hardly comparable.
• Southern Blotting and quantitative PCR are similar in their reproducibility.
• Laboratories measuring telomere length should use a common set of physical standards.
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of fully blinded telomere length assessments according to
their established in-house methodology. DNA samples ra-
ther than cells or tissues were used in order to minimize
preparative variation, so only laboratories performing
Southern blot, STELA or qPCR were included. Results of
this study indicate important methodological limitations
when attempting to compare data between different labo-
ratories, even on a relative scale.
Methods
Participants
Laboratories were invited to participate in the study on the
basis of an active publication record in the field. The 10
participating laboratories are listed in Supplementary
Table 1, available as Supplementary data at IJE online).
Elsewhere in this report, participating laboratories are dis-
tinguished by code numbers which are independent of the
order in which they are listed in Supplementary Table 1.
Four further laboratories were invited to participate. Two
of these teams elected instead to conduct their own joint
study of telomere length measurement.14 Two further
groups were no longer actively performing telomere length
measurements when invited.
Methods for telomere length assessment
Two laboratories (labs 1 and 2) applied their established
Southern blotting method (South). One laboratory (lab 3)
used the STELA technique, and seven laboratories (labs
4–10) used PCR-based methods (qPCR). Methodological
details are given in Supplementary Table S1A (for qPCR
methods) and S1B (for gel-based methods) (available as
Supplementary data at IJE online). As STELA combines
features of both, it is included in both supplementary
tables.
Samples
Samples were selected to provide a good coverage of the
various kinds of human DNA material that might be en-
countered in routine work of this nature and thus included
tumour and somatic cell DNA as well as DNA isolated
from human tissue and human leukocytes (Table 1).
The study was performed in two fully separated rounds
to enable assessment of both intra- and inter-batch vari-
ation. All DNA samples were generated at the Newcastle,
UK, laboratory by QIAamp DNA extraction (Qiagen,
Manchester, UK) and their quality and concentration were
assessed by both UV spectroscopy and agarose gel electro-
phoresis. OD260/280 values were from 1.88 to 2.05, and
OD260/230 ranged from 1.92 to 2.81. Samples were ali-
quoted (5 mg DNA per sample for TRF analysis and 0.5 mg
per sample for qPCR and STELA measurements) and sent
to an independent distributor team (MRC Unit for
Lifelong Health and Ageing at UCL, London, UK) which
individually re-coded and shipped to the participating lab-
oratories and kept the code unbroken until all results had
been returned. In the first round, 10 samples (A, B, C, D,
E, F, G, H, I and J) were sent. The second round was
started only after all data from the first round had been
received, to enable the comparison of measurements per-
formed in independent batches. This round included five
repeat samples from the first round (B, C, G, H, I), of
which samples C, G and H were duplicated, and two new
samples (K and L) of actual donor DNA to distinguish
Table 1. DNA samples
Sample code Sample identity Comments
Sample A BJ-T telomerized human fibroblast subclone A Human BJ fibroblasts were telomerized30 and subclones
were grown separately for at least 3 months to generate
different telomere lengths
Sample B BJ-T telomerized human fibroblast subclone B
Sample C BJ-T telomerized human fibroblast subclone C
Sample D BJ-T telomerized human fibroblast subclone D
Sample E Human placenta DNA High-molecular-weight DNA from a single human placenta
(Sigma D3035, lot 123K3739)
Sample F HeLa Human cervical adenocarcinoma cell line (ATCC #CCl-2)
Sample G SH-SY5Y subclone G Human neuroblastoma cell line (ATCC #CRL-2266).
Subclones were grown separately for at least 3 months,
generating different telomere lengths
Sample H SH-SY5Y subclone H
Sample I SH-SY5Y subclone I
Sample J SH-SY5Y subclone J
Sample K Pooled leukocyte DNA from 3 donors aged between
21 and 52 years
Sample L Pooled leukocyte from 4 donors aged between 21
and 67 years
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from cultured cell-lines DNA. Only the Newcastle labora-
tory was aware of this information, but was blinded as
every other participant to the identity of the samples
received from the independent distributor. Once all results
were returned the codes were broken and statistical ana-
lysis was performed.
Data analysis and statistical methods
Since variations between laboratories and methods are
expected to give rise to systematic differences in raw esti-
mates of telomere length, the primary focus of this study
has been to examine the reliability and consistency of as-
sessment of relative telomere lengths, rather than absolute
length. For this purpose, telomere length ratios (TLRs)
were calculated using a chosen sample as reference. Unless
otherwise indicated, TLR values in the remainder of this
paper refer to the ratio of the estimated telomere length for
a particular sample, divided by the estimated telomere
length for sample G. In round 2, where a blind-coded
duplicate of sample G was included, the value of just one
of the duplicates was used as the reference sample, since
this allowed assessment of the precision of performing
repeated assessments of samples which, unknown to the
laboratories at the time of assessment, were identical. To
additionally compensate for differences in the dynamic
range of measurements, z-scores were calculated from raw
data. In addition to comparing method- and laboratory-
specific coefficients of variation (CVs), a General Linear
Model (GLM) analysis with normalized telomere length as
dependent variable and method and laboratory as factors
was performed; we employed this method to determine if a
statistically significant difference in telomere length was
evident between laboratories (labs), methods and also to
test for a lab vs method interaction. All statistical ana-
lyses were performed using IBM SPSS Statistics v19 and
STATA v13.
Results
From 190 samples sent out for analysis, results were re-
turned for 185. For five samples (two for lab 3, one each
for labs 1, 4 and 6) results did not meet the internal quality
standards of the laboratory as outlined in Supplementary
Table S1 (available as Supplementary data at IJE online)
and no data were returned. Specifically, lab 1 did not
measure sample L (second round) because of low quality
restriction digest, lab 3 obtained insufficient DNA mol-
ecules for amplification from samples E (first round) and C
(2 second round) and sample H failed quality control
[as defined in Supplementary Table S1 (available as
Supplementary data at IJE online)] in lab 4 (first round)
and in lab 6 (second round). Lab 10 was only invited to
participate after round 1 was already completed, but
performed two separate qPCR assays (one-tube and two-
tube). Raw data for telomere length (laboratories 1–3) or
T/S ratios (laboratories 4–10) are given in Supplementary
Table S2 (available as Supplementary data at IJE online).
As expected, the values differed widely. To enable com-
parisons, the returned values were standardized to TLRs.
These data are given in Table 2, together with the inter-
laboratory CV for each sample. In general, similar TLR
estimates were obtained from all laboratories (Figure 1)
and correlations between data from all participants as
shown in the scatterplots (Supplementary Figure S1,
available as Supplementary data at IJE online) were
strong. Corresponding rank correlation coefficients
(Supplementary Table S3, available as Supplementary data
at IJE online) between TLRs measured in different labora-
tories ranged between 0.63 and 0.99. Correlations between
laboratories within each technique separately were stron-
ger (with no differences between Southern blot and qPCR)
than those between Southern blot and qPCR results
(Supplementary Figure S1 and Supplementary Table S3,
available as Supplementary data at IJE online).
To measure the variation of the TLR estimates between
laboratories, we calculated CVs for every sample as meas-
ured by all laboratories and separately as measured by
qPCR or Southern/STELA (Table 2). This variability be-
tween laboratories was high: the median CV between all
labs is 24.17% with individual sample CVs higher than
50% (Table 2). Although rank correlations within the
qPCR labs were equally high as the gel-based techniques
(Supplementary Table S3, available as Supplementary data
at IJE online), a comparison of the inter-lab CVs showed
that there is significantly (P¼ 0.001, paired t test) less in-
ter-laboratory variability between the Southern blotting
and STELA techniques than within the qPCR laboratory
results (Table 2). This is not caused by the higher number
of participating qPCR laboratories; after calculating CVs
for all possible triplet combinations of qPCR laboratories,
their median is still far higher than that for the gel-based
techniques (Table 2). The samples with the shortest TLRs
(E, F and H) caused the largest differences in inter-labora-
tory CVs between qPCR and Southern/STELA (Table 2).
This is related to a systematic bias in the estimates of short
telomeres between qPCR on one hand and Southern blot
and STELA on the other. Figure 1 shows that Southern
and STELA techniques reproducibly generate higher esti-
mates for shorter telomere samples than qPCR. In other
words, the dynamic range for low TLR estimates that
ranges from 0.2 to 0.8 for the qPCR technique is com-
pressed to about 0.5 to 1.0 in the Southern and STELA
data. These differences between the techniques become
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more obvious when comparing averages per sample and
technique. Figure 2 shows a linear association between
Southern/STELA and qPCR estimates with an offset of
0.556 0.32 [mean6 standard error of the mean (SEM)],
which may be attributable to a contribution from subtelo-
meric DNA to the Southern blotting estimates. In addition,
the slope of the regression (1.386 0.30) is significantly
(P¼ 0.001) greater than 1. Importantly, Figure 2 shows
that the dynamic range (the ratio of the lowest to the
highest value) for the qPCR technique (7.83) is more
than 3-fold greater than for Southern/STELA (2.51)
techniques. Thus, it appears that the greater variation
of estimates between different qPCR laboratories may
be compensated for by a higher linear range. This was
confirmed when dynamic range differences between
laboratories were compensated for by z-scoring. For
this measure, inter-laboratory variances between the qPCR
laboratories were, on average, not larger than those for
the Southern/STELA techniques (Supplementary Table S4,
available as Supplementary data at IJE online). However,
these variances were still large with medians amounting
to between 23% (qPCR) and 30% (all techniques com-
bined) of the standard deviation (SD) of the examined
population.
Variation within laboratories was tested separately for
both intra- and inter-batch variation. To test intra-batch
variation, three samples in round 2 were duplicated. These
samples were measured fully blinded on the same gel
(Southern and STELA) or the same plate (qPCR). CVs
ranging between 0.000 and 31.299 for individual samples
and laboratories are given in Table 3. There are no signifi-
cant differences between the laboratories (ANOVA;
P¼ 0.299). A summary of intra-batch CVs per technique is
shown in Figure 3a. Median intra-batch CVs were small at
1.86% (South), 2.83% (STELA) and 4.57% (qPCR)
(Figure 3a). Differences between the techniques were not
significant (P¼ 0.161, Kruskal-Wallis ANOVA on ranks).
Even if CVs from South and STELA were combined (me-
dian CV¼ 2.40), the difference to the qPCR results
Figure 1. Telomere length ratios (TLRs) by laboratory, round and sample. TLRs are normalized to sample G, first round. Symbols indicate laboratories
and techniques: n Lab 1 South; ~ Lab 2 South; 6 Lab 3 STELA; ~ Lab 4 qPCR; u Lab 5 qPCR; Q Lab 6 qPCR; n Lab 7 qPCR; D Lab 8 qPCR; e Lab 9
qPCR;  Lab 10 qPCR duplex;* Lab 10-2 qPCR monoplex .
Figure 2. Correlation between TLRs measured by Southern blotting/
STELA vs qPCR. Data are scatterplots of means (6 SD) of sample TLRs
per technique. Results from rounds 1 and 2 are combined. Linear re-
gression (solid line) and 95% confidence intervals (dotted) are shown.
The correlation coefficient is r2¼ 0.676.
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remained non-significant (P¼ 0.075, Mann-Whitney Rank
Sum test).
Any larger study will rely on comparisons of data gener-
ated in separate batches. Therefore, inter-batch variation
was tested in each laboratory (excluding lab 10) using five
fully blinded duplicated samples between rounds 1 and 2.
Results are given in Table 4. Median CVs per laboratory
could be as low as 1.10% (lab 8) or as high as 11.52%
(lab 7). However, the differences between the participating
laboratories were not statistically significant (P¼ 0.195,
Kruskal-Wallis ANOVA on ranks). Median inter-batch
CVs (Figure 3b) were 3.62% (South), 4.78% (STELA) and
4.65% (qPCR), indicating no difference in performance
between techniques (P¼ 0.840, Kruskal-Wallis ANOVA
on ranks). Interestingly, for the qPCR technique, intra- and
inter-assay variation were not different, suggesting intra-
assay variation as the major contributor to overall vari-
ance, whereas plate-to-plate variation seems minor or well
corrected for.
To compare accuracy between all participating labora-
tories, we combined both intra- and inter-batch
estimates (Figure 3c). Although there was a tendency for
some laboratories using either the Southern (lab 2) or
the qPCR (lab 8) technique to generate lower variation
than others, differences over all laboratories were only
borderline significant (P¼ 0.060, Kruskal-Wallis ANOVA
Figure 3. Coefficients of variation by technique and laboratory. Box plots indicate median (central line), upper and lower quartiles (boxes), upper and
lower centiles (whiskers) and outliers (dots). (a) Intra-batch CVs per technique. (b) Inter-batch CVs per technique. (c) Intra-laboratory CVs (both intra-
and inter-batch CVs combined).
Table 3. Intra-batch CVs per laboratory
Sample name Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 Lab 7 Lab 8 Lab 9 Lab 10 Lab 10-2
South South STELA qPCR qPCR qPCR qPCR qPCR qPCR qPCR qPCR
C 1.702 0.178 12.339 7.799 1.903 4.771 4.566 3.354 11.934 31.299
G 4.614 3.481 2.784 1.781 2.162 2.156 4.721 0.324 0.470 7.095 20.089
H 1.083 2.007 2.869 2.397 7.018 8.985 3.861 0.000 2.404 6.264
Table 4. Inter-batch CVs per laboratory
Sample name Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 Lab 7 Lab 8 Lab 9
South South STELA qPCR qPCR qPCR qPCR qPCR qPCR
B 13.388 1.499 16.228 12.826 3.046 5.215 11.522 7.431 11.314
C 15.305 3.368 12.915 16.190 3.564 1.652 28.906 1.709 3.973
G 2.270 1.719 1.379 0.896 1.073 1.086 2.322 0.162 0.235
H 8.813 2.980 2.720 11.650 8.925 7.144 0.850 13.671
I 3.877 7.991 4.775 4.652 2.175 8.620 22.052 1.093 7.395
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on ranks). Similarly, when variation was estimated based
on z-scored data, there was no significant difference be-
tween techniques or individual laboratories (data not
shown).
To further compare the impacts of technique and la-
boratory on result variance, a generalized linear model was
constructed with technique and laboratory as factors.
Testing the null hypothesis of equal variance for normal-
ized telomere length in all groups resulted in an F¼1.650,
corresponding to P¼ 0.096, confirming borderline signifi-
cance for standard deviations between labs and techniques.
However, partial eta-squared coefficients were low (tech-
nique: 0.000, laboratory: 0.013, technique x laboratory:
0.000), indicating that neither technique nor laboratory
had strong influence on result variation.
Discussion
This is the first study to undertake a comparison of telo-
mere length measurements across a wide group of labora-
tories with expertise in three different techniques. For the
present blind coded comparison study we used DNA sam-
ples that originated from a single laboratory and therefore
differences between laboratories or between methods can-
not be attributed to pre-analytical conditions such as cell
culture, blood sample anticoagulant or collection proced-
ure, alternative DNA isolation or storage methods, etc.
Recently it had been shown that DNA extraction methods
can have a significant impact on both mean value and
dynamic range of telomere length estimates by qPCR,24
but this source of variation has been excluded in our study.
Our samples covered a range of about 3 to 11 kb, i.e. the
full range of telomere length variation typically encoun-
tered in human studies.
We did not attempt a comparison between absolute
data as returned from the participating laboratories be-
cause these varied even more than the TLRs, both between
and within techniques.
Our main result is that rank correlations between labo-
ratories are high but there is a large variation of TLR esti-
mates between different laboratories. With a median CV of
24% between laboratories, this variation is much larger
than differences between control and case groups in typical
telomere biomarker studies, which are generally in the
order of 3–10%. The large variation between laboratories
is partly driven by systematic differences between qPCR-
and gel-based techniques, especially in measuring short
telomeres. Systematic differences between Southern and
qPCR results have been found before.14, 15 In all reported
studies, the dynamic range of Southern blot results was
lower than that of the corresponding qPCR data,14,15,22
similar to our findings (see Figure 2). The existence of a
curvilinear association between Southern blot and qPCR
data has been proposed14 but this was not strongly sup-
ported by others15,22 or by the present study (see Figure 2).
However, our results indicate that the most pronounced
differences between Southern blot and qPCR estimates are
found for shortest telomere lengths (see Figure 1). These
differences could probably be due to different approaches
to generating ‘average’ telomere length. It has been sug-
gested that the weighted average as calculated by both
Southern labs in the present study might underestimate
‘true’ telomere length.25 In contrast, qPCR techniques
estimate ‘average’ telomere length essentially as the total
template amount per cell without weighting.
The possibility remains that these large variations and
systematic differences are at the root of the inconsistencies
found in the literature.12,15,26 The larger part of the inter-
laboratory variation stems from apparently random vari-
ation between qPCR laboratories (median 20.7%). This
lower reproducibility between laboratories using the qPCR
technique is, however, compensated for by a larger dy-
namic range of the qPCR measurements. Accordingly,
inter-laboratory variation is no longer different between
the techniques if calculated on the basis of z-scored data.
It had been suggested that inherent methodological vari-
ation might be higher for the qPCR method as compared
with Southern blotting.27,14 Addressing inherent methodo-
logical variation by comparing blinded measurements done
in each laboratory on the same or on separate batches, our
data do not support this notion. The number of participat-
ing laboratories using Southern blotting and STELA in our
study was still small; however, this reflects the worldwide
trend to use qPCR for telomere length measurements, espe-
cially in biomarker studies. Importantly, participating lab
numbers were sufficient to allow for the first time some
statistical confidence in a comparison of gel-based and
qPCR techniques. Our study design gave us >95% power
to detect a difference between CVs in gel-based vs qPCR
methods of the size found in a previous comparison
between two laboratories only.14 Such a difference does
not exist if multiple laboratories are included in the com-
parison between the techniques. On the contrary, both
mean CVs and their variation were very similar for the
techniques.
Laboratory-specific intra- and inter-batch CVs have
been reported in the literature over a range from 1.25% to
12% for Southern blotting and 2.27% to 28% for
qPCR.4,12,14,28 Our data, generated in a fully blinded fash-
ion, are well within this range. Our study had 50–75%
power to detect differences in accuracy between individ-
ual laboratories in a one-to-one comparison with 95%
confidence. This was just not sufficient to prove the exist-
ence of differences in accuracy between laboratories in a
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multiple comparison of non-normally distributed data.
Importantly, differences in accuracy between laboratories,
if they exist at all, are similarly found among qPCR and
Southern labs.
The amount of methodological differences between labo-
ratories was large. Six different qPCR labs used four different
reference genes (36B4, beta-haemoglobin, GAPDH, ALB)
and differed in their application of a duplex or monoplex ap-
proach, in use of primers, master mix compositions and ther-
mal cycling profiles, in the brands of qPCR systems used
(Roche LightCycler; Bio-Rad MyiQ or CFX384; Rotorgene
6000 RT Thermal Cycler; Applied Biosystems ABI7900 ther-
mal cycler) and in the normalization techniques applied to
correct for well-to-well and/or plate-to-plate variations.
Similarly, Southern protocols differed in multiple parameters
between laboratories, including DNA restriction protocols,
electrophoresis conditions, the molecular weight marker and
the probe labelling as well as the use (or not) of internal
batch-to-batch controls (see Supplementary Table S1, avail-
able as Supplementary data at IJE online).
In essence, every single laboratory had developed its
own combination of interdependent methodological details
in an approach to optimize outcomes. This means that an
‘observational’ study like ours was not designed to assess
the impact of these methodological differences on result
variability, even if it would include larger numbers of sam-
ples and/or laboratories. However, the results from our
study might be used to suggest a follow-up ‘interventional’
study, in which laboratories change certain methodological
details to see whether this might improve variability of re-
sults (see conclusions below). One obvious post hoc study
was an assessment of the impact of different reference
genes on the variation of results between qPCR laborato-
ries. This might be specifically relevant because some of
the DNA samples were from tumour cells showing various
degrees of genetic imbalance, which might lead to different
gene dosages for the reference genes. Therefore, a post hoc
analysis comparing 36B4, beta-haemoglobin and GAPDH
as reference genes was performed in a single laboratory
(Supplementary Table S5, available as Supplementary data
at IJE online). Whereas results using different reference
genes in the same lab correlated highly (rank correlation
coefficients >0.85), correlations to the blinded results
from different labs using the same reference gene were not
better than those using different reference genes. In other
words, use of different reference genes did not explain the
variation between qPCR labs.
Conclusions
Our results demonstrate large inter-laboratory variation
even for relative telomere lengths following internal
normalization. This means that reference ranges for telo-
mere lengths that may be applied by all laboratories cannot
be given in the present state of the art. In other words, ‘the’
telomere length of an individual (or a group of individuals)
does not exist as a measurable quantity, and even a technic-
ally perfect telomere length measurement could only be use-
ful as a risk indicator if reference values were measured by
the same laboratory using the same protocols. Z-scoring of
data appears at present the best possibility for combining re-
sults from different laboratories. However, this may result
in large errors, which can easily reach median values around
500 bp telomere length in typical human populations.
Our data suggest that it would be both possible and use-
ful to develop optimized protocols that will reduce intra-
and inter-lab variation. As a first step, we propose that a
set of telomere length standards should be generated to
share among interested parties (including both scientific
and commercial laboratories). If these were analysed with
each major study, it would for the first time enable stand-
ardization of results and their comparison between labora-
tories. However, natural telomeres (i.e. in telomerizzed
cells in culture) are not constant in length between sub-
clones (Table 1) or with time29 and thus not well suited as
reference standards. A perfectly reproducible standard for
qPCR could be generated by use of synthetic double-
stranded gene fragments containing copies of both a telo-
meric and a reference gene sequence in a 1:1 stochiometry.
Serially diluted, this fragment would generate the standard
curve for the telomere target in the high concentration
range and for the reference gene at low concentrations.
The dilution factor ratio would be used to normalize T/S
ratios measured in the unknown samples. Cross-standard-
ization with Southern blotting would enable quantification
of qPCR results in base pairs from the slope of the regres-
sion between Southern results and fragment-normalized
qPCR data. Conversely, Southern data could be standar-
dized against fragment-normalized qPCR.
Regarding further steps towards inter-lab methodological
standardization, our results do not immediately suggest
measures that would reduce result variation with high prob-
ability. For instance, comparing variation between qPCR
labs, we found no preference for a single reference gene, nei-
ther appeared a multiplex approach to be more reproducible
than a monoplex one. Similarly, it was not clear which
(combination) of methodological differences between the
two Southern labs could be responsible for the tendency to-
wards a lower CV in lab 2. Moreover, we recognize that
groups use different pieces of equipment, for which different
reagents and protocols are optimal. However, the groups
involved in the present study have started discussions about
ways to test protocol variations, and we invite all interested
laboratories to join and to contribute to further studies.
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The importance of telomere biology in human disease is
increasingly recognized and, in parallel, use of telomere
length (TL) measures is proliferating in epidemiological and
clinical studies. Such studies measure leukocyte TL (LTL)
using several methodological approaches. Shorter LTL is
associated with atherosclerosis1 and all-cause mortality.2
Given the increasingly recognized role of TL in human age-
ing and its related diseases, it is essential to know more
about the reliability and validity of TL measurement meth-
ods, their comparability and which method is optimal for a
specific epidemiological/clinical setting.
In an effort to address this knowledge gap, Martin-Ruiz
et al. (MR)3 studied the reliability of TL measurement
techniques. They compared the popular qPCR method
with the labour-intensive Southern blots (SBs) and single
telomere length analysis (STELA). MR concluded that ‘nei-
ther technique nor laboratory had strong influence on re-
sult variation’, and that ‘Southern blotting and qPCR are
similar in their reproducibility’. Unfortunately, for the fol-
lowing reasons we believe that for epidemiological studies
neither conclusion is justified by the data.
Reliability of LTL
Most DNA samples (10/12) used by MR were obtained
from human placenta, cell cultures and cancer cells.
However, the inter-assay reliability of LTL is the pertinent
parameter for epidemiological studies. MR included only
two DNA samples from leukocytes and, because these
were added in the second round of the study, they could
not be used to measure inter-assay reliability of LTL. TL
results for human placenta, cultured and cancer cells can-
not be automatically generalized to LTL reliability, which
is the primary concern of epidemiologists. Note also that
MR used pooled leukocyte samples of multiple donors,
and effects of pooling on assay reliability can therefore not
be excluded. A previous comparison of LTL reliability has
been done for the SB and the qPCR methods in a study4
cited by MR. The study reported a clear difference in inter-
assay coefficient of variation (CV) between SB ¼ 1.74%
and qPCR ¼ 6.54%, using 50 leukocyte DNA samples
from individual donors. Moreover, Steenstrup et al.5 inves-
tigated whether LTL elongation in longitudinal studies can
be attributed to measurement error vs a real biological
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